You may want to visit the Exhibit Hall at CHEST 2016 for the complimentary lunch, morning coffee breaks, or the afternoon treats, but we promise the Exhibit Hall will impress you with more than just food. The Exhibit Hall is your resource for the latest advances in chest medicine, including three learning theaters with more than 15 presentations, a Critical Care Skills Workshop, GAMEs, and much more.
Plus, here are some of our exhibitors that you won’t want to miss:
PAH research grants!
Stop by Gilead Sciences’ Medical Information Booth to learn about the Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension and the 2016 awardees. The program’s mission is to support innovative scientific research that will advance knowledge in the field of PAH and provide support for research career development. Three awards will be provided this year, with each award funded up to $130,000, to be paid in annual installments of up to $65,000 per year for 2 years. Recipients of these competitive awards are selected by an independent Scientific Review Committee comprised of leaders in the field of PAH.
Artwork. Yes, artwork.
Insmed is committed to transforming the lives of patients with serious and rare diseases, like NTM (nontuberculous mycobacteria) lung infections. Insmed reached out to NTM patients to learn about their journey to an NTM diagnosis. They connected these patients with a diverse range of artists from around the world to bring the impact of NTM to life with vivid imagery. The initiative, A Thousand Words About NTM, uses the patients’ stories, their words, to inspire artists to create one-of-a-kind original artwork. These works of art have helped patients communicate what they’ve often struggled to put into words—the long, difficult journey to an NTM diagnosis. This exciting and unique project strives to raise awareness about NTM lung infections because, “What could be worse than having NTM? Not knowing you have NTM.”
Advancing the research of inhaled therapies
AstraZeneca will showcase its commitment to advancing the research of inhaled therapies, including novel combinations and targeted medicines to help address unmet needs for respiratory patients and to transform the treatment paradigm. Attendees visiting the booth will have the opportunity to “Explore, Experience and Engage” with AZ’s current products, create patient education materials, and learn about different areas of AstraZeneca respiratory research.
Severe homogeneous emphysema? There’s a “valve” for that.
Pulmonx will present interesting new data on the use of endobronchial valves for patients with severe homogeneous emphysema. Additionally, Pulmonx will present key data showing that using Quantitative CT plus Chartis is more accurate than either method alone for predicting responders to EBV therapy.
Located in the South Hall of the convention center, the Exhibit Hall is open the following hours:
Monday, October 24, 2016, 10:00 am – 4:00 pm
Tuesday, October 25, 2016, 10:00 am – 3:00 pm
Wednesday, October 26, 2016, 10:00 am – 2:30 pm
We hope to see you in the Exhibit Hall in October!